Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Overview of attention for article published in Frontiers in oncology, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 103 Mendeley

Summary News X Patents

So far, Altmetric has seen 1 X post from an account with 6,531 followers.

New research: Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Cetuximab remains to date the only targeted therapy approved for the treatment of head and neck squamous cell… https://t.

21 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.